| 2.1 |
6.2 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 2.0 |
16.3 |
GO:1901748 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 2.0 |
6.0 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 1.7 |
5.0 |
GO:0051714 |
regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
| 1.7 |
5.0 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) |
| 1.6 |
8.0 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 1.4 |
10.0 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 1.3 |
1.3 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 1.3 |
16.4 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 1.2 |
4.9 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 1.1 |
3.2 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 1.1 |
5.3 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.1 |
3.2 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.1 |
4.2 |
GO:0010901 |
regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
| 1.0 |
3.0 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 1.0 |
1.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.9 |
2.8 |
GO:2000388 |
positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) |
| 0.9 |
3.7 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.9 |
2.7 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.9 |
2.6 |
GO:0002149 |
hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
| 0.8 |
2.5 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.8 |
2.5 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.8 |
2.4 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.8 |
2.4 |
GO:0006589 |
octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
| 0.8 |
3.2 |
GO:0002752 |
cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.8 |
3.2 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
| 0.8 |
2.3 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.8 |
2.3 |
GO:0014064 |
positive regulation of serotonin secretion(GO:0014064) |
| 0.8 |
3.0 |
GO:0090345 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.8 |
5.3 |
GO:0015840 |
urea transport(GO:0015840) |
| 0.7 |
1.5 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.7 |
2.9 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.7 |
10.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.7 |
2.9 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.7 |
2.9 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.7 |
2.1 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.7 |
2.8 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.7 |
6.2 |
GO:0070944 |
neutrophil mediated killing of bacterium(GO:0070944) |
| 0.7 |
2.7 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.7 |
0.7 |
GO:2000724 |
regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 0.7 |
0.7 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.6 |
4.4 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.6 |
3.1 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.6 |
2.5 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.6 |
0.6 |
GO:0070943 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) |
| 0.6 |
3.6 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.6 |
1.8 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.6 |
2.4 |
GO:0035502 |
metanephric part of ureteric bud development(GO:0035502) |
| 0.6 |
2.9 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.6 |
2.9 |
GO:0072181 |
mesonephric duct formation(GO:0072181) |
| 0.6 |
2.3 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.6 |
1.7 |
GO:0061090 |
positive regulation of sequestering of zinc ion(GO:0061090) |
| 0.6 |
1.7 |
GO:0072382 |
minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 0.6 |
5.6 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.6 |
3.4 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.6 |
1.7 |
GO:0002344 |
peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
| 0.6 |
0.6 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.5 |
1.6 |
GO:0001698 |
gastrin-induced gastric acid secretion(GO:0001698) |
| 0.5 |
1.6 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.5 |
1.6 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 0.5 |
1.6 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.5 |
2.6 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.5 |
3.6 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.5 |
1.5 |
GO:0002017 |
regulation of blood volume by renal aldosterone(GO:0002017) |
| 0.5 |
2.0 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.5 |
2.0 |
GO:0072053 |
renal inner medulla development(GO:0072053) |
| 0.5 |
1.5 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.5 |
2.0 |
GO:0002540 |
leukotriene production involved in inflammatory response(GO:0002540) |
| 0.5 |
2.4 |
GO:0010956 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
| 0.5 |
2.4 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.5 |
2.4 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.5 |
9.0 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.5 |
0.5 |
GO:0060197 |
cloacal septation(GO:0060197) |
| 0.5 |
1.8 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.5 |
2.3 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.5 |
1.4 |
GO:0000239 |
pachytene(GO:0000239) |
| 0.4 |
0.4 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
3.1 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.4 |
1.3 |
GO:0031662 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.4 |
1.3 |
GO:0009093 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.4 |
1.8 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.4 |
1.3 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.4 |
0.4 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.4 |
2.2 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.4 |
3.1 |
GO:0030421 |
defecation(GO:0030421) |
| 0.4 |
1.7 |
GO:0035962 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.4 |
6.5 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.4 |
1.3 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 0.4 |
1.3 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.4 |
0.9 |
GO:0071608 |
macrophage inflammatory protein-1 alpha production(GO:0071608) |
| 0.4 |
3.9 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.4 |
3.4 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.4 |
1.3 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.4 |
1.7 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.4 |
2.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 |
0.8 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.4 |
1.2 |
GO:0002277 |
myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 0.4 |
1.2 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.4 |
4.1 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 |
1.2 |
GO:0071846 |
actin filament debranching(GO:0071846) |
| 0.4 |
1.2 |
GO:2000597 |
optic nerve formation(GO:0021634) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
| 0.4 |
0.8 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) |
| 0.4 |
1.2 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.4 |
0.4 |
GO:1904057 |
negative regulation of sensory perception of pain(GO:1904057) |
| 0.4 |
1.6 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
| 0.4 |
1.2 |
GO:2000016 |
negative regulation of determination of dorsal identity(GO:2000016) |
| 0.4 |
0.4 |
GO:0035419 |
activation of MAPK activity involved in innate immune response(GO:0035419) |
| 0.4 |
1.6 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.4 |
0.8 |
GO:0072236 |
metanephric loop of Henle development(GO:0072236) |
| 0.4 |
1.9 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.4 |
1.2 |
GO:0045796 |
negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.4 |
43.5 |
GO:0007586 |
digestion(GO:0007586) |
| 0.4 |
2.7 |
GO:1904222 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 |
0.8 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.4 |
1.1 |
GO:0002353 |
plasma kallikrein-kinin cascade(GO:0002353) |
| 0.4 |
0.8 |
GO:2000043 |
regulation of cardiac cell fate specification(GO:2000043) |
| 0.4 |
0.7 |
GO:0034635 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.4 |
0.4 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.4 |
1.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.4 |
0.7 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.4 |
1.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.4 |
1.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.3 |
1.4 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.3 |
1.4 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.3 |
3.1 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 |
0.3 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
| 0.3 |
1.4 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.3 |
1.4 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.3 |
1.7 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 |
5.2 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 |
2.4 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.3 |
0.3 |
GO:0051794 |
regulation of catagen(GO:0051794) |
| 0.3 |
0.7 |
GO:0051885 |
positive regulation of anagen(GO:0051885) |
| 0.3 |
3.4 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 |
5.4 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.3 |
1.0 |
GO:0035524 |
proline transmembrane transport(GO:0035524) |
| 0.3 |
3.0 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 |
3.3 |
GO:0035878 |
nail development(GO:0035878) |
| 0.3 |
0.3 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.3 |
0.3 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.3 |
0.6 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.3 |
1.0 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.3 |
1.0 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.3 |
4.8 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.3 |
3.2 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.3 |
1.3 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.3 |
0.3 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.3 |
1.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 |
0.3 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.3 |
0.6 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 |
5.1 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.3 |
0.3 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.3 |
1.5 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.3 |
3.0 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.3 |
0.9 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
10.1 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.3 |
0.3 |
GO:0070100 |
regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.3 |
0.9 |
GO:0010666 |
positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.3 |
1.5 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.3 |
2.3 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.3 |
1.7 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.3 |
2.6 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.3 |
0.9 |
GO:0002325 |
natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 0.3 |
0.6 |
GO:0042376 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.3 |
3.7 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.3 |
1.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.3 |
0.3 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.3 |
1.4 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.3 |
0.3 |
GO:0060983 |
epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
| 0.3 |
0.6 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.3 |
1.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.3 |
1.7 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) |
| 0.3 |
0.8 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.3 |
1.1 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.3 |
0.8 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 |
0.5 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.3 |
0.8 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.3 |
0.8 |
GO:0035926 |
chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
| 0.3 |
1.3 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 |
0.5 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.3 |
0.5 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.3 |
0.5 |
GO:0022009 |
central nervous system vasculogenesis(GO:0022009) |
| 0.3 |
0.3 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.3 |
1.6 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.3 |
0.5 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.3 |
2.1 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.3 |
2.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.3 |
1.1 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.3 |
0.8 |
GO:0014718 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.3 |
0.3 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.3 |
1.6 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
0.8 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.3 |
2.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.3 |
1.8 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.3 |
0.5 |
GO:0097534 |
lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.3 |
1.8 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.3 |
2.0 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.3 |
0.5 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.3 |
0.8 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.3 |
2.0 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.3 |
0.5 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
0.8 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.2 |
1.7 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.2 |
1.2 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 0.2 |
1.5 |
GO:0035865 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.2 |
2.5 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.2 |
0.7 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.2 |
1.0 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.2 |
1.5 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.2 |
2.5 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
1.2 |
GO:0018992 |
germ-line sex determination(GO:0018992) |
| 0.2 |
0.7 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.2 |
1.0 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.2 |
1.5 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.2 |
0.5 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.2 |
1.0 |
GO:0048691 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 0.2 |
0.2 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 0.2 |
1.9 |
GO:0002441 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.2 |
0.5 |
GO:0033483 |
gas homeostasis(GO:0033483) |
| 0.2 |
0.7 |
GO:0072003 |
kidney rudiment formation(GO:0072003) |
| 0.2 |
0.5 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.2 |
1.2 |
GO:0015820 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.2 |
4.7 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.2 |
0.9 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.2 |
2.6 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 |
0.5 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.2 |
1.4 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.2 |
4.4 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.2 |
0.7 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 |
0.9 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 |
1.6 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.2 |
0.7 |
GO:0070904 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
5.2 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.2 |
1.3 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.2 |
0.9 |
GO:1904566 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.2 |
3.3 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 |
3.3 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.2 |
0.4 |
GO:0032415 |
regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
0.9 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.2 |
0.4 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.2 |
1.8 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 |
0.7 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) positive regulation of progesterone secretion(GO:2000872) |
| 0.2 |
1.5 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
0.4 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) |
| 0.2 |
0.2 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.2 |
0.9 |
GO:0009816 |
defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
| 0.2 |
0.9 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.2 |
1.3 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 |
0.9 |
GO:1905165 |
peptidyl-aspartic acid modification(GO:0018197) regulation of lysosomal protein catabolic process(GO:1905165) |
| 0.2 |
3.0 |
GO:0048935 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.2 |
1.5 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.2 |
0.6 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
0.2 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 0.2 |
0.6 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.2 |
1.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
0.6 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.2 |
0.6 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) hemangioblast cell differentiation(GO:0060217) |
| 0.2 |
0.8 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
0.4 |
GO:0055093 |
response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
| 0.2 |
0.4 |
GO:1905146 |
lysosomal protein catabolic process(GO:1905146) |
| 0.2 |
0.6 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.2 |
1.0 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
1.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.2 |
1.2 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 |
1.8 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.2 |
0.2 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.2 |
6.4 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.2 |
0.2 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.2 |
0.8 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 |
1.0 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
0.4 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.2 |
2.0 |
GO:0051025 |
negative regulation of immunoglobulin secretion(GO:0051025) |
| 0.2 |
1.0 |
GO:0038094 |
Fc-gamma receptor signaling pathway(GO:0038094) |
| 0.2 |
1.0 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.2 |
1.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.2 |
0.6 |
GO:0072366 |
regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.2 |
0.4 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.2 |
0.4 |
GO:2000586 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 0.2 |
0.8 |
GO:2000510 |
positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.2 |
0.2 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
1.0 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
1.5 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.2 |
1.3 |
GO:0014832 |
urinary bladder smooth muscle contraction(GO:0014832) |
| 0.2 |
0.4 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.2 |
1.7 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.2 |
2.7 |
GO:1904659 |
glucose transmembrane transport(GO:1904659) |
| 0.2 |
0.2 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.2 |
0.6 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 |
1.9 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.7 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.2 |
0.7 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
0.2 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.2 |
0.7 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 |
0.6 |
GO:0061526 |
acetylcholine secretion(GO:0061526) |
| 0.2 |
0.6 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.2 |
0.6 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.2 |
0.9 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
0.5 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.2 |
0.7 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.2 |
1.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.2 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 |
0.4 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.2 |
0.7 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) |
| 0.2 |
0.9 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.2 |
0.5 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 |
0.5 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.2 |
1.4 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.2 |
0.2 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.2 |
2.3 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.2 |
0.3 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) |
| 0.2 |
1.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
0.5 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.2 |
0.7 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 |
0.3 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.2 |
0.3 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.2 |
0.7 |
GO:0015855 |
nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
| 0.2 |
0.5 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.2 |
1.5 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.2 |
0.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 |
1.0 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.2 |
1.0 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.2 |
1.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
1.2 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.2 |
0.5 |
GO:0045660 |
positive regulation of neutrophil differentiation(GO:0045660) |
| 0.2 |
0.3 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 0.2 |
1.5 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
0.5 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.2 |
1.8 |
GO:0070431 |
nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.2 |
1.3 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.2 |
1.2 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.2 |
0.5 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.2 |
0.3 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 |
0.8 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 |
0.7 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.2 |
0.7 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.2 |
0.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 |
1.0 |
GO:0002238 |
response to molecule of fungal origin(GO:0002238) |
| 0.2 |
0.8 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.2 |
0.5 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.2 |
0.5 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 |
0.5 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.2 |
0.5 |
GO:2001293 |
malonyl-CoA metabolic process(GO:2001293) |
| 0.2 |
1.8 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.2 |
0.8 |
GO:0021853 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.2 |
0.3 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.2 |
0.8 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.2 |
0.3 |
GO:0001998 |
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
| 0.2 |
1.6 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 |
0.8 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.2 |
1.9 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.2 |
0.9 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.2 |
0.3 |
GO:0071395 |
response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.2 |
0.9 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 |
0.5 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.2 |
0.8 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 |
4.0 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.2 |
0.9 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
1.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.2 |
1.5 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.2 |
1.5 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.2 |
0.5 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.2 |
0.3 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.2 |
0.6 |
GO:0042891 |
antibiotic transport(GO:0042891) |
| 0.2 |
0.5 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 |
1.2 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.2 |
0.5 |
GO:0051944 |
positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.2 |
0.6 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.2 |
0.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.2 |
0.5 |
GO:0002355 |
detection of tumor cell(GO:0002355) |
| 0.2 |
0.6 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 |
0.3 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 |
1.0 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.1 |
1.3 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.1 |
0.4 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.6 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.1 |
0.9 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
0.4 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.1 |
0.1 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.1 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.1 |
2.0 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.1 |
0.7 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.7 |
GO:0061438 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.1 |
0.4 |
GO:0071907 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.1 |
0.3 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.1 |
0.6 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.1 |
0.3 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.1 |
0.6 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.1 |
0.6 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) |
| 0.1 |
0.8 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.1 |
GO:0009227 |
nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 |
0.6 |
GO:0036476 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.1 |
0.7 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
0.8 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
1.2 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
0.4 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.1 |
1.0 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.8 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.1 |
0.5 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.1 |
0.5 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.1 |
1.1 |
GO:0071402 |
cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.1 |
1.6 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.7 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.1 |
0.1 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
0.7 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.1 |
2.0 |
GO:0001946 |
lymphangiogenesis(GO:0001946) |
| 0.1 |
2.8 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.3 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.1 |
0.3 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.1 |
0.3 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.5 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.1 |
1.0 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.3 |
GO:0002580 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
| 0.1 |
1.2 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.1 |
GO:0090154 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.4 |
GO:0060768 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
4.9 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
1.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.6 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 |
0.1 |
GO:0086068 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.1 |
0.3 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 |
1.0 |
GO:2000810 |
regulation of bicellular tight junction assembly(GO:2000810) |
| 0.1 |
0.5 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 |
0.3 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.1 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.1 |
2.0 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.1 |
0.3 |
GO:1904849 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 |
0.6 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.1 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.1 |
0.4 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.1 |
0.5 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.3 |
GO:0030908 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.1 |
1.3 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
0.4 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.1 |
2.3 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.3 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.1 |
0.4 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.5 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.1 |
0.4 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.1 |
0.2 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.1 |
0.2 |
GO:0032532 |
regulation of microvillus length(GO:0032532) |
| 0.1 |
0.2 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.1 |
0.9 |
GO:0052205 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
1.0 |
GO:0032274 |
gonadotropin secretion(GO:0032274) |
| 0.1 |
0.5 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
1.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.6 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.1 |
1.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.5 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
1.4 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.6 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.1 |
1.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.6 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.8 |
GO:0021889 |
olfactory bulb interneuron differentiation(GO:0021889) |
| 0.1 |
0.2 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.4 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.1 |
0.5 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.4 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 |
0.4 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.1 |
1.5 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 |
1.4 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
0.1 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 |
0.5 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.1 |
1.2 |
GO:1902175 |
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
| 0.1 |
1.8 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) |
| 0.1 |
0.2 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.1 |
0.1 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.1 |
1.2 |
GO:0035313 |
wound healing, spreading of epidermal cells(GO:0035313) |
| 0.1 |
0.6 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.1 |
2.0 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.1 |
1.9 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
2.2 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.1 |
0.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.1 |
1.8 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.1 |
0.8 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.2 |
GO:0032277 |
negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 0.1 |
0.6 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.2 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.4 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 |
0.2 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.1 |
0.2 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.1 |
0.3 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.3 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.1 |
1.1 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
0.3 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.1 |
2.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.1 |
GO:0060300 |
regulation of cytokine activity(GO:0060300) |
| 0.1 |
0.4 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 0.1 |
0.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 |
1.5 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.1 |
0.7 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.9 |
GO:0014841 |
skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.1 |
0.2 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.1 |
1.7 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.1 |
0.4 |
GO:2000523 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.1 |
0.4 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.2 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.1 |
0.4 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.1 |
0.1 |
GO:1903874 |
ferrous iron transmembrane transport(GO:1903874) |
| 0.1 |
0.6 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 |
0.4 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
1.6 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
0.7 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.4 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.7 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
1.0 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.1 |
0.1 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.1 |
0.4 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
0.7 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.3 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.2 |
GO:0045341 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.1 |
0.4 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.1 |
0.6 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.5 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.3 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.1 |
4.6 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.1 |
0.3 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
0.3 |
GO:0035854 |
basophil differentiation(GO:0030221) eosinophil fate commitment(GO:0035854) |
| 0.1 |
0.5 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.1 |
1.8 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.1 |
0.2 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
1.3 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.1 |
0.3 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
1.8 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.1 |
1.8 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
2.8 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 |
0.3 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.8 |
GO:0045606 |
positive regulation of epidermal cell differentiation(GO:0045606) |
| 0.1 |
0.4 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.1 |
0.9 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.1 |
0.3 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.4 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.2 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 |
0.2 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.4 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.4 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.5 |
GO:2000020 |
positive regulation of male gonad development(GO:2000020) |
| 0.1 |
0.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.4 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 |
0.2 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 |
0.6 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
0.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
2.2 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.6 |
GO:1901186 |
positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
0.4 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.4 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.3 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
4.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.3 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.1 |
0.5 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.3 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
1.6 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
0.6 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
0.4 |
GO:0033575 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 |
1.0 |
GO:0070254 |
mucus secretion(GO:0070254) |
| 0.1 |
0.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
0.3 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
0.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.2 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.1 |
0.3 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
1.3 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
0.6 |
GO:0009251 |
glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
1.0 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.1 |
0.5 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.1 |
0.8 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.1 |
0.3 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.1 |
0.3 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.1 |
0.3 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.1 |
0.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
1.5 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
7.7 |
GO:0090277 |
positive regulation of peptide hormone secretion(GO:0090277) |
| 0.1 |
0.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.4 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
2.4 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
1.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.2 |
GO:0071613 |
granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 0.1 |
0.7 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.5 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
1.2 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.2 |
GO:0099526 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.1 |
0.7 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.3 |
GO:0061187 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 |
1.0 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.1 |
0.2 |
GO:0003051 |
angiotensin-mediated drinking behavior(GO:0003051) |
| 0.1 |
2.0 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.1 |
0.7 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.6 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
1.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.4 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
1.2 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
0.1 |
GO:0007571 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
0.9 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.1 |
0.2 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.1 |
0.3 |
GO:2001245 |
negative regulation of cellular amine metabolic process(GO:0033239) regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 |
0.7 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.1 |
0.3 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.2 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.3 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 |
0.2 |
GO:1900477 |
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
| 0.1 |
0.2 |
GO:0042482 |
positive regulation of odontogenesis(GO:0042482) |
| 0.1 |
4.8 |
GO:0051453 |
regulation of intracellular pH(GO:0051453) |
| 0.1 |
0.2 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 |
0.3 |
GO:0072272 |
proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.1 |
0.5 |
GO:0061641 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
0.8 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
2.1 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.7 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.1 |
0.2 |
GO:2000570 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.1 |
0.4 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.1 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) |
| 0.1 |
0.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.4 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
2.2 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.4 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 |
0.3 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.1 |
0.3 |
GO:0006272 |
leading strand elongation(GO:0006272) |
| 0.1 |
0.2 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.2 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 |
0.1 |
GO:0048382 |
mesendoderm development(GO:0048382) corticotropin hormone secreting cell differentiation(GO:0060128) |
| 0.1 |
0.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
0.6 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 |
0.6 |
GO:1900264 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.2 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 |
1.5 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.6 |
GO:0098910 |
T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) regulation of atrial cardiac muscle cell action potential(GO:0098910) |
| 0.1 |
0.2 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.1 |
0.8 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 |
0.9 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
0.8 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
2.9 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
0.6 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.7 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.1 |
GO:0043519 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.1 |
1.7 |
GO:0003143 |
embryonic heart tube morphogenesis(GO:0003143) |
| 0.1 |
0.1 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 |
0.5 |
GO:0015809 |
arginine transport(GO:0015809) |
| 0.1 |
0.1 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.2 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 |
0.1 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.1 |
0.3 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.1 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.1 |
0.1 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.3 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
0.1 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 0.1 |
0.4 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.1 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
0.1 |
GO:2001280 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.1 |
0.1 |
GO:0060168 |
regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.1 |
0.2 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.1 |
0.6 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.1 |
0.4 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
| 0.1 |
0.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
2.1 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
0.2 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.1 |
0.2 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.1 |
0.6 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.1 |
0.1 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.1 |
0.6 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.1 |
0.2 |
GO:0035087 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
0.1 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.1 |
0.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.1 |
1.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.3 |
GO:0006833 |
water transport(GO:0006833) |
| 0.1 |
0.3 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
0.3 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
0.7 |
GO:0048643 |
positive regulation of skeletal muscle tissue development(GO:0048643) |
| 0.1 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.4 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.1 |
1.8 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.1 |
0.2 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
0.1 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.2 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.1 |
0.3 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.6 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.6 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.3 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
2.6 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 |
0.3 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 |
0.2 |
GO:0045625 |
regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.1 |
0.2 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.1 |
0.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.2 |
GO:1903632 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.1 |
0.5 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.4 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 |
0.1 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.1 |
0.2 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 |
0.3 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
0.9 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.5 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
2.4 |
GO:0006909 |
phagocytosis(GO:0006909) |
| 0.1 |
0.5 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 |
0.2 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.1 |
1.3 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
1.0 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.9 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.1 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.1 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.3 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.5 |
GO:0070862 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.2 |
GO:0007314 |
oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
| 0.1 |
0.3 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.5 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.1 |
0.4 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.1 |
0.1 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.1 |
0.9 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.3 |
GO:0002579 |
positive regulation of antigen processing and presentation(GO:0002579) |
| 0.1 |
0.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.1 |
1.2 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.4 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.4 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
3.7 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.1 |
0.6 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
0.2 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.1 |
0.5 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
0.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.4 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.3 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.1 |
1.4 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.1 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 0.1 |
0.1 |
GO:0052200 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.0 |
0.3 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.2 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.2 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.0 |
0.1 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.0 |
0.2 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.1 |
GO:0015881 |
creatine transport(GO:0015881) |
| 0.0 |
0.0 |
GO:0060331 |
negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
| 0.0 |
0.4 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.0 |
0.2 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 0.0 |
2.5 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 0.0 |
1.3 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 |
0.2 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 |
0.1 |
GO:0048880 |
medulla oblongata development(GO:0021550) hindbrain tangential cell migration(GO:0021934) sensory system development(GO:0048880) |
| 0.0 |
0.2 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.1 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.0 |
0.1 |
GO:0000915 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.0 |
1.5 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.5 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.2 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.6 |
GO:0030502 |
negative regulation of bone mineralization(GO:0030502) |
| 0.0 |
0.3 |
GO:0045631 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.3 |
GO:0072537 |
fibroblast activation(GO:0072537) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.0 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.0 |
0.2 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.0 |
0.1 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.0 |
0.2 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.5 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.0 |
0.5 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 |
0.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.6 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.0 |
1.2 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.5 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.0 |
0.1 |
GO:1904579 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.0 |
0.4 |
GO:0044257 |
cellular protein catabolic process(GO:0044257) |
| 0.0 |
0.3 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.2 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 |
0.8 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.0 |
0.2 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.0 |
0.9 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.2 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 |
0.1 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 |
0.0 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.6 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 |
0.2 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.0 |
0.7 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.4 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:0050927 |
positive regulation of positive chemotaxis(GO:0050927) |
| 0.0 |
0.1 |
GO:1990918 |
double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.0 |
0.1 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.0 |
0.2 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.0 |
0.0 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.0 |
2.6 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.4 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 |
0.1 |
GO:0071799 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.0 |
0.2 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 |
0.1 |
GO:0019859 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.0 |
0.4 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.2 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.0 |
4.5 |
GO:0006006 |
glucose metabolic process(GO:0006006) |
| 0.0 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.1 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.1 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.6 |
GO:0002548 |
monocyte chemotaxis(GO:0002548) |
| 0.0 |
0.2 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.0 |
0.1 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.1 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.2 |
GO:0051709 |
regulation of killing of cells of other organism(GO:0051709) |
| 0.0 |
1.1 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.4 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.0 |
0.1 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.0 |
0.5 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.0 |
0.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.0 |
0.3 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.6 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.2 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.5 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 |
0.1 |
GO:0098971 |
anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 0.0 |
0.4 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.1 |
GO:0010226 |
response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
| 0.0 |
0.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.2 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.5 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.2 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.0 |
0.1 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.0 |
0.1 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.0 |
0.7 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
0.1 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.0 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.0 |
0.0 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.0 |
0.1 |
GO:2000321 |
positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.0 |
0.2 |
GO:0032377 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 |
0.8 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.3 |
GO:0045598 |
regulation of fat cell differentiation(GO:0045598) |
| 0.0 |
0.1 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.0 |
0.1 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.7 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.4 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.4 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.7 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.1 |
GO:0031620 |
regulation of fever generation(GO:0031620) |
| 0.0 |
0.8 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
0.2 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.0 |
0.2 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.1 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.8 |
GO:0015986 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.1 |
GO:0035268 |
protein mannosylation(GO:0035268) |
| 0.0 |
0.0 |
GO:0003091 |
renal water homeostasis(GO:0003091) |
| 0.0 |
0.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.1 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.0 |
0.2 |
GO:0010623 |
programmed cell death involved in cell development(GO:0010623) |
| 0.0 |
1.0 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.7 |
GO:0006336 |
DNA replication-independent nucleosome assembly(GO:0006336) |
| 0.0 |
0.5 |
GO:0042102 |
positive regulation of T cell proliferation(GO:0042102) |
| 0.0 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.3 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.3 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.0 |
0.4 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.0 |
0.5 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.2 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.2 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.0 |
0.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.4 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.2 |
GO:0036003 |
positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
| 0.0 |
3.0 |
GO:0050953 |
sensory perception of light stimulus(GO:0050953) |
| 0.0 |
0.0 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.7 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.0 |
0.6 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.7 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.0 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.0 |
0.3 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.7 |
GO:0071514 |
genetic imprinting(GO:0071514) |
| 0.0 |
0.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.2 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 |
0.2 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.0 |
0.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 |
0.2 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.0 |
0.4 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.1 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.0 |
0.1 |
GO:0061525 |
hindgut development(GO:0061525) |
| 0.0 |
0.1 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.0 |
0.2 |
GO:2000758 |
positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.0 |
0.1 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.0 |
0.2 |
GO:0001836 |
release of cytochrome c from mitochondria(GO:0001836) |
| 0.0 |
0.3 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
0.2 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.2 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.2 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.0 |
0.2 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.1 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 |
0.4 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.0 |
0.2 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.0 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.5 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.1 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.0 |
0.1 |
GO:0045815 |
positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.0 |
0.3 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.0 |
0.5 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.0 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) |
| 0.0 |
0.2 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.4 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 0.0 |
0.7 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.0 |
0.2 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.2 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.1 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.0 |
0.0 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.0 |
0.0 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 |
0.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.3 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.7 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.0 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.0 |
0.1 |
GO:2000327 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.0 |
0.5 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.7 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 |
0.2 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.0 |
GO:0035933 |
glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
| 0.0 |
0.2 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 |
0.1 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.0 |
0.2 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.0 |
0.0 |
GO:1902571 |
regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.1 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
0.0 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.0 |
0.2 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
0.2 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.0 |
0.5 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.0 |
0.1 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.0 |
0.1 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.0 |
0.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.0 |
0.1 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.0 |
0.0 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.0 |
0.2 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 |
0.1 |
GO:0035879 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.3 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.0 |
GO:0034093 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.0 |
0.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.0 |
0.1 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.0 |
0.1 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.2 |
GO:0052697 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.0 |
0.4 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.0 |
0.2 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 |
0.1 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.3 |
GO:0061180 |
mammary gland epithelium development(GO:0061180) |
| 0.0 |
1.2 |
GO:0035308 |
negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 |
0.0 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.0 |
0.2 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.3 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.0 |
0.5 |
GO:0006073 |
glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.0 |
0.1 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.1 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.0 |
0.0 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 |
0.1 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.0 |
0.2 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
0.5 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.2 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.0 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.0 |
0.0 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.0 |
GO:0071462 |
cellular response to water stimulus(GO:0071462) |
| 0.0 |
0.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 |
0.1 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.0 |
0.0 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.0 |
0.0 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.0 |
0.0 |
GO:1900102 |
negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
| 0.0 |
0.0 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.0 |
0.1 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.0 |
0.0 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.0 |
0.0 |
GO:0045616 |
regulation of keratinocyte differentiation(GO:0045616) |
| 0.0 |
0.1 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.2 |
GO:0021983 |
pituitary gland development(GO:0021983) |
| 0.0 |
1.0 |
GO:0002377 |
immunoglobulin production(GO:0002377) |
| 0.0 |
0.1 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.0 |
0.1 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.0 |
0.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.2 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
0.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.0 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.1 |
GO:2000757 |
negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.0 |
0.1 |
GO:0035247 |
peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.0 |
0.1 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 |
0.2 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
16.8 |
GO:0006508 |
proteolysis(GO:0006508) |
| 0.0 |
0.1 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 |
0.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.1 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.1 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 |
0.0 |
GO:0015865 |
purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.0 |
0.2 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.0 |
0.0 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.0 |
0.1 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.0 |
0.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.0 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.0 |
0.0 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.0 |
0.0 |
GO:0070230 |
positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of leukocyte apoptotic process(GO:2000108) |
| 0.0 |
0.1 |
GO:0015909 |
long-chain fatty acid transport(GO:0015909) |
| 0.0 |
0.0 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.0 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.0 |
0.0 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.0 |
0.0 |
GO:1905038 |
regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.0 |
0.0 |
GO:0009223 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |